Patent · US Active

Substituted imidazoquinolines

US9073913B2 · kind B2 · utility

2Cited by
4References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2009
Grant dateJul 7, 2015
Priority date
Expiry dateOct 29, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.